Skip to main content
MEDICLINIC INTERNATIONAL PLC logo

MEDICLINIC INTERNATIONAL PLC — Investor Relations & Filings

Ticker · MDC ISIN · US58471Q1004 LEI · 2138002S5BSBIZTD5I60 IL Human health and social work activities
Open in API
Filings indexed 628 across all filing types
Latest filing 2025-10-02 Major Shareholding Noti…
Country GB United Kingdom
Listing IL MDC

About MEDICLINIC INTERNATIONAL PLC

https://www.mediclinic.com/en/home.html

Mediclinic International PLC is a diversified international private healthcare services group focused on providing specialist-orientated, multi-disciplinary services across the continuum of care. The company's clinical offerings include acute care, outpatient consultations, pre-hospital emergency services, day case surgery, and inpatient care. With a core purpose to enhance the quality of life, the group emphasizes delivering high-quality, patient-centric healthcare. Mediclinic operates with a sustainable, long-term approach, upholding high standards of clinical governance and investing in skilled professionals, advanced facilities, and modern medical equipment to be a trusted provider for clients, medical practitioners, and funders.

Recent filings

Filing Released Lang Actions
Form 8.3 - SPIRE HEALTHCARE GROUP PLC
Major Shareholding Notification Classification · 1% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more during an M&A transaction. While it relates to M&A activity, it is specifically a disclosure of shareholding positions rather than a merger announcement or takeover bid document itself. Given the specific nature of these disclosures regarding major shareholdings in the context of a takeover, it fits best as a Major Shareholding Notification (MRQ).
2025-10-02 English
De-listing and cancellation of trading of shares
Delisting Announcement Classification · 1% confidence The document is an RNS announcement (indicated by 'RNS Number : 0349B') detailing the final steps of a recommended cash acquisition (takeover) of Mediclinic International plc by Manta Bidco Limited. The core subject is the '# DE-LISTING AND CANCELLATION OF TRADING OF MEDICLINIC SHARES' following the Scheme becoming Effective. This announcement is about the consequence of a takeover, specifically the delisting of shares from the London Stock Exchange, JSE, and NSX. This event is directly related to a major corporate transaction involving a change in control/ownership structure, which falls under the scope of M&A Activity (TAR). However, the primary, immediate action announced is the delisting itself. Since 'Delisting Announcement' (DLST) is a specific category for the official notice that stock will be removed from an exchange, and this document explicitly announces the cancellation of listing and trading, DLST is the most precise fit for the content of this specific filing, even though it is a consequence of a takeover (TAR). Given the explicit focus on delisting, DLST is chosen over TAR.
2023-05-30 English
Scheme of Arrangement becomes effective
M&A Activity Classification · 1% confidence The document is an RNS announcement (indicated by 'RNS Number : 7948A') dated May 26, 2023. The primary subject is the finalization of a 'RECOMMENDED CASH ACQUISITION' of Mediclinic International plc by Manta Bidco Limited via a 'Scheme of Arrangement'. Key phrases include 'SCHEME OF ARRANGEMENT BECOMES EFFECTIVE', details on settlement, suspension/cancellation of listing, and director resignations following the scheme's effectiveness. This document announces a major corporate transaction (takeover/acquisition) and its immediate consequences, including delisting and board changes. This falls under the category of M&A Activity (TAR). While it is an RNS announcement, the content is highly specific to a takeover/merger event, making TAR a more precise classification than the general fallback RNS.
2023-05-26 English
Director/PDMR Shareholding
Remuneration Information Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement dated May 25, 2023, titled "NOTIFICATION: TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES & PERSONS CLOSELY ASSOCIATED WITH THEM". It details the vesting of share awards (LTIP/STI) for several Directors and PDMRs (Persons Discharging Managerial Responsibilities) of Mediclinic International plc. This type of mandatory disclosure concerning insider transactions (directors' dealings) falls directly under the definition of Director's Dealing (DIRS). Although it is published via RNS, the specific content dictates the DIRS classification over the general RNS fallback.
2023-05-25 English
Form 8 (DD) - Mediclinic International plc
Director's Dealing Classification · 1% confidence The document is explicitly titled 'FORM 8 (DD) PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT' and references 'Rules 8.1, 8.2 and 8.4 of the Takeover Code'. This form is used to disclose personal share transactions by directors or persons acting in concert during a takeover situation. This directly matches the definition for Director's Dealing (DIRS), which covers personal share transactions by company directors and executives (insider trades), although in this context it is specifically related to a takeover offer. Since the core action is the disclosure of a director's dealing (Mr Ahmed Ali) in relation to an offer, DIRS is the most appropriate specific code. It is not a general regulatory filing (RNS) because it is a highly specific disclosure type (Form 8 DD).
2023-05-25 English
Court Sanction of Scheme of Arrangement
AGM Information Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement from Mediclinic International plc, dated May 25, 2023. The primary subject is the 'RECOMMENDED CASH ACQUISITION' of Mediclinic by Manta Bidco Limited, specifically announcing the 'COURT SANCTION OF SCHEME OF ARRANGEMENT' and providing a 'FINALISATION ANNOUNCEMENT WITH REVISED TIMETABLE'. This clearly relates to a takeover or merger activity (M&A). The definition for M&A Activity (TAR) covers 'Announcements and documents related to merger proposals or takeover bids.' Although it is distributed via RNS, the core content is a definitive update on a takeover scheme, making TAR the most specific classification. The document mentions the Scheme Document and provides detailed timetables for the acquisition process, confirming it is a substantive announcement about the transaction itself, not just a general regulatory update (RNS) or a delisting notice (DLST), although delisting is a consequence mentioned later in the timetable.
2023-05-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.